1. Home
  2. CCS vs ANIP Comparison

CCS vs ANIP Comparison

Compare CCS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCS
  • ANIP
  • Stock Information
  • Founded
  • CCS 2000
  • ANIP 2001
  • Country
  • CCS United States
  • ANIP United States
  • Employees
  • CCS N/A
  • ANIP N/A
  • Industry
  • CCS Homebuilding
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCS Consumer Discretionary
  • ANIP Health Care
  • Exchange
  • CCS Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • CCS 1.9B
  • ANIP 2.0B
  • IPO Year
  • CCS 2014
  • ANIP N/A
  • Fundamental
  • Price
  • CCS $63.13
  • ANIP $92.85
  • Analyst Decision
  • CCS Buy
  • ANIP Strong Buy
  • Analyst Count
  • CCS 4
  • ANIP 7
  • Target Price
  • CCS $80.75
  • ANIP $99.14
  • AVG Volume (30 Days)
  • CCS 351.6K
  • ANIP 343.4K
  • Earning Date
  • CCS 10-22-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • CCS 1.82%
  • ANIP N/A
  • EPS Growth
  • CCS N/A
  • ANIP N/A
  • EPS
  • CCS 6.93
  • ANIP N/A
  • Revenue
  • CCS $4,157,669,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • CCS N/A
  • ANIP $39.99
  • Revenue Next Year
  • CCS $10.71
  • ANIP $9.57
  • P/E Ratio
  • CCS $9.20
  • ANIP N/A
  • Revenue Growth
  • CCS N/A
  • ANIP 38.68
  • 52 Week Low
  • CCS $50.42
  • ANIP $52.50
  • 52 Week High
  • CCS $95.76
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • CCS 53.06
  • ANIP 51.08
  • Support Level
  • CCS $61.35
  • ANIP $90.06
  • Resistance Level
  • CCS $64.46
  • ANIP $96.99
  • Average True Range (ATR)
  • CCS 2.13
  • ANIP 2.63
  • MACD
  • CCS 0.56
  • ANIP 0.06
  • Stochastic Oscillator
  • CCS 67.14
  • ANIP 55.91

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: